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Dear editor
We read with interest the article “Cortical spreading depression produces a 
neuroprotective effect activating mitochondrial uncoupling protein-5” published 
in Neuropsychiatr Dis Treat by Viggiano et al.1 The authors showed that cerebral 
spreading depression (CSD) triggered uncoupling protein-5 (UCP-5),1 which had been 
reported to exert a long-term effect upon neuron protection.2 The result is another 
piece in CSD literature on modifying gene expressions to provide neuroprotection to 
subsequent ischemic episodes.3,4
An unmentioned but additional factor for neuroprotection in CSD could be 
acidosis.
Acidosis is a known consequence of CSD.5 In the literature, brief acidosis in 
ischemic conditions when oxygen supply is low has been shown to be cytoprotec-
tive and neuroprotective,6–10 a result related sometimes to the concept of the “pH 
paradox.”9,11,12 Acidosis had been reported to reduce stroke infarct size with CO
2
 
applied for a short time after reperfusion6 as well as during ischemic stroke.10 Brief 
acidosis applied after birth asphyxia7 was reported to successfully suppress brain alka-
losis, which led to seizures. Hence, brief and relatively mild acidosis induced under 
the condition of CSD may be one of the neuroprotective factors for CSD. The role of 
acidosis in neuroprotection by CSD warrants further investigation.
Interestingly, CSD-induced acidosis could be one explanation of impaired cerebral 
vascular reactivity13–16 after CSD. It has been reported that once tissue reaches a certain 
low pH threshold, blood flow increase would be insignificant in response to even 
stronger CO
2
 challenge.10
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Dear editor
Thank you for the attention paid to our article entitled: 
“Cortical spreading depression produces a neuroprotective 
effect activating mitochondrial uncoupling protein-5”.1 We do 
agree that cerebral spreading depression (CSD)-induced aci-
dosis is an intriguing aspect of the neuroprotection puzzle. It 
is well known that CSD is involved in the pathophysiology 
of migraine, cerebral ischemia, subarachnoid hemorrhage, 
and traumatic brain injury.2–7 Moreover, it is also involved in 
traumatic and spontaneous intracerebral hemorrhage, as well 
as in migraine aura and epilepsy.8–10 The induction of CSD 
during ischemia causes an increase in tissue damage, while 
preconditioning with CSD decreases the damage induced 
by a subsequent episode of ischemia.11 Anyway, the mecha-
nisms underlying these effects, as well as the neuroprotection 
induced by CSD, remain unclear.
Our results are consistent with the hypothesis that CSD 
might induce its neuroprotective effect by means of uncou-
pling electron transport from ATP synthesis, mediated by 
the activation of the mitochondrial uncoupling proteins 
(UCPs). Such an idea is supported by the experimental 
evidence of the neuroprotective effect due to upregulation 
of UCPs in response to oxidative stress; in fact, reactive 
oxygen species seem to play a major role in the phenomenon 
of ischemia–reperfusion.12 But, reperfusion itself induces 
also an important inflammatory response, characterized 
by a massive production of free radicals and by the acti-
vation of the complement and leukocytes. Therefore, the 
intracellular acidosis, the oxidative stress, the production 
of cytokines, and the secondary mitochondrial lesions may 
represent competing factors involved in the CSD-induced 
neuroprotection.11–15
Therefore, according to authors’ letter, further studies are 
needed to prove this multifaceted reality.
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